RxDoctor Payments Data

Robert Boguski, DPM

Podiatrist · Roanoke, VANPI 1770143919

Payments from drug & device makers

What this record shows

This record is dominated by education: $9,239 of the $11,862 with a category attached, or 77.9%. Pinnacle, Inc accounts for 78.4% of it on its own, with 19 other manufacturers making up the rest. Reporting peaked in 2021 at $3,941 and has fallen 91.3% since, to $344 in 2025. Among podiatrist clinicians in VA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$11,862in general payments, 2019–2025

Across 69 payments — averaging $171.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pinnacle, Inc$9K
  • Johnson & Johnson$810
  • Stryker$185
  • Smith+Nephew$183
  • Bioventus LLC$171
  • Integra Lifesciences Corporation$165
  • plus $1K from 14 others

What the payments were for

  • Food & beverage$2,62222%
  • Education$9,23978%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,862 in reported general payments places this provider in the 90th percentile of 126 podiatrist providers in Virginia.

See all podiatrist providers in Virginia

Medicare billing

Part B allowed, 2024
$79,196
Medicare patients
214
Services billed
962

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciclopirox28$478
Clotrimazole12$117
Meloxicam18$29

Paid to pharmacies, not to this prescriber.

Other podiatrist in Roanoke

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →